Japan
· Delayed Price · Currency is JPY Takara Bio Statistics
Total Valuation
Takara Bio has a market cap or net worth of JPY 101.63 billion. The enterprise value is 73.23 billion.
| Market Cap | 101.63B |
| Enterprise Value | 73.23B |
Important Dates
The last earnings date was Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Takara Bio has 120.42 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 120.42M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 9.77% |
| Float | 46.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 40.51 |
| PS Ratio | 2.36 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.84, with an EV/FCF ratio of -17.86.
| EV / Earnings | -1,408.34 |
| EV / Sales | 1.70 |
| EV / EBITDA | 12.84 |
| EV / EBIT | 65.86 |
| EV / FCF | -17.86 |
Financial Position
The company has a current ratio of 6.78
| Current Ratio | 6.78 |
| Quick Ratio | 4.66 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 55.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 1.00% |
| Revenue Per Employee | 23.42M |
| Profits Per Employee | -28,292 |
| Employee Count | 1,838 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.27 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.23% in the last 52 weeks. The beta is 0.24, so Takara Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -16.23% |
| 50-Day Moving Average | 993.42 |
| 200-Day Moving Average | 1,037.57 |
| Relative Strength Index (RSI) | 23.48 |
| Average Volume (20 Days) | 481,375 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Takara Bio had revenue of JPY 43.05 billion and -52.00 million in losses. Loss per share was -0.43.
| Revenue | 43.05B |
| Gross Profit | 25.24B |
| Operating Income | 1.11B |
| Pretax Income | 968.00M |
| Net Income | -52.00M |
| EBITDA | 5.71B |
| EBIT | 1.11B |
| Loss Per Share | -0.43 |
Balance Sheet
| Cash & Cash Equivalents | 28.71B |
| Total Debt | n/a |
| Net Cash | 28.71B |
| Net Cash Per Share | 238.38 |
| Equity (Book Value) | 109.00B |
| Book Value Per Share | 902.66 |
| Working Capital | 45.53B |
Cash Flow
In the last 12 months, operating cash flow was 6.11 billion and capital expenditures -10.21 billion, giving a free cash flow of -4.10 billion.
| Operating Cash Flow | 6.11B |
| Capital Expenditures | -10.21B |
| Free Cash Flow | -4.10B |
| FCF Per Share | -34.05 |
Margins
Gross margin is 58.62%, with operating and profit margins of 2.58% and -0.12%.
| Gross Margin | 58.62% |
| Operating Margin | 2.58% |
| Pretax Margin | 2.25% |
| Profit Margin | -0.12% |
| EBITDA Margin | 13.25% |
| EBIT Margin | 2.58% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 17.00, which amounts to a dividend yield of 1.96%.
| Dividend Per Share | 17.00 |
| Dividend Yield | 1.96% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | 1.96% |
| Earnings Yield | -0.05% |
| FCF Yield | -4.03% |
Stock Splits
The last stock split was on March 29, 2011. It was a forward split with a ratio of 400.
| Last Split Date | Mar 29, 2011 |
| Split Type | Forward |
| Split Ratio | 400 |
Scores
Takara Bio has an Altman Z-Score of 8.87.
| Altman Z-Score | 8.87 |
| Piotroski F-Score | n/a |